GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (NSE:DIVISLAB) » Definitions » Payments of Debt

Divi's Laboratories (NSE:DIVISLAB) Payments of Debt : ₹0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories Payments of Debt?

Divi's Laboratories's Payments of Debt for the three months ended in Dec. 2023 was ₹0 Mil.

Divi's Laboratories's Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0 Mil.

Divi's Laboratories Payments of Debt Historical Data

The historical data trend for Divi's Laboratories's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Divi's Laboratories Payments of Debt Chart

Divi's Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -610.70 -332.80 -3.50 -

Divi's Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Divi's Laboratories Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Divi's Laboratories Payments of Debt Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Divi's Laboratories (NSE:DIVISLAB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (NSE:DIVISLAB) » Definitions » Payments of Debt
Comparable Companies
BOM:500124 BOM:543904 NSE:TORNTPHARM BOM:532321 BOM:500257 NSE:AUROPHARMA NSE:ALKEM BOM:524494 BOM:532331 BOM:506943 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
532488:India
Address
Divi Towers, 1-72/23(P)/DIVIS/303, Babukhan Lane, Cyber Hills, Gachibowli, Hyderabad, TG, IND, 500032
Website
https://www.divislabs.com
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. Most of the company's sales are generated in Europe, followed by North America, India, and Asia. The company has three distinct business segments: Generic APIs, Custom Synthesis, and Nutraceuticals. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Divi's Laboratories (NSE:DIVISLAB) Headlines

No Headlines